Altair
Skip to content

Trading Analysis Report: GEV

Analysis date: 2026-10-14 · Model: claude-opus-5-5 · AI-generated, not financial advice.

  • Analysis date: 2026-10-14
  • Rating: Underweight
  • Generated: 2026-10-14 14:52:03
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Underweight

Executive Summary: Underweight GEV: trim existing holdings ahead of the Oct 28 Q3 print and the FOMC decision, but do not exit, because the higher-timeframe trend and the business are intact. Reduce to a target residual equal to a ~3% loss budget divided by the larger of the options-implied event move and 8.7%. That is roughly 0.30-0.35x of a standard allocation, with a 0.25x floor, a 0.4x hard guardrail, and 0.3x if the implied move is unavailable. Place resting sell limits at 970-975 from Thursday once the 10/14 bar is final; otherwise sell at least one-third by the Oct 20 close (or down to 1.0x if overweight), two-thirds by Oct 23 and all by Oct 27, and go straight to target over two sessions on any daily close below 910.39. Add no new money and no add-backs until both events are absorbed, treat 837.76 as a post-event line for the residual rather than gap protection, and note the price target is 846.5 over 2-3 months; flat holders should simply not buy, not short.

Current Price: 941.78

Price Target: 846.5

Confidence: Medium

Time Horizon: 2-3 months

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: Let me open with the part people usually get backwards. Selling here isn't the timid choice. The timid choice is holding a full position into October 28 and 29 because the weekly trend is still up and nobody wants to be wrong. The bold move is to cut a crowded, richly valued stock by half right before a binary event, and to accept that I might hand back some upside if the print is great.

Start with the price. GEV is about 96 times annualized Q2 operating income, and Q2 EPS annualizes to roughly $9.88, which puts it near 95x. The 26.8x trailing P/E is a mirage. Q1 net income was $4.7B on $179M of operating income, so that's a huge non-operating gain. The bull case needs real operating leverage to grow into this multiple, and the incremental operating margins we've actually seen are 10.4% in Q1 and 13.8% in Q2. The trend path that earns about 10% a year from here needs something closer to 24%. Gross margin improving to 21.3% is real progress, but the market is paying for perfection on a 5.9% operating margin. The cash flow doesn't rescue the story either. TTM free cash flow is about four times EBITDA, which looks like customer deposits and working capital, and that can reverse as projects ship.

The tape says the market is starting to notice. The stock gapped down 6.2% on the heaviest volume since September 18, and it lost the 10 EMA, the 50 SMA and the Bollinger midline in one session. It's holding the 200 SMA by 1.2%, after trading below it intraday. ADX is 17, the MACD histogram is 0.17 and about to cross, and the daily SuperTrend stop is under one ATR away. That's the fourth drop of 6% or more in four months. This stock gaps hard, and it gaps down more often than the bulls like to admit.

Then the calendar. Earnings are October 28 and the FOMC is October 29. The prediction market has a 30% chance of a hike, up 15 points in a week, with 10-year yields reportedly at their highest since 2002. Those are headline and prediction-market sources, since our FRED data failed, so I won't pretend the levels are verified. But a long-duration stock at 66x or more shouldn't go into back-to-back event days at full size.

Now the pushback I expect. If the conservative analyst says exit entirely, I'd say that's a false sense of safety. The weekly and monthly SuperTrends are both up, with the weekly stop at 837.76 and the monthly at 635. The backlog is reportedly $176B, and the data-center demand story isn't a fabrication. A full exit makes a concentrated bet that the thesis is dead, and nothing in the data says that. Keeping half is the aggressive part of this plan. If orders come in at $24B or more, I still own half and participate.

If the neutral analyst says hold because every higher-timeframe trend is intact, I'd point out that a weekly stop 11% below the current price isn't protection. It's a license to ride out an 11% drawdown. On a half-size residual that costs roughly five and a half percent of a standard allocation, which I can live with, but not on a full position into a possible 8.7% gap to about 860 followed by a hawkish Fed.

The bullish evidence is mostly priced in or crowded. Retail is 82% bullish on a labeled sample of just 11 posts. Cramer is touting it, there's stock-split chatter with no company announcement behind it, and people were buying near-the-money calls around 980 and 1,000 the day before the drop. Insiders have sold about $20.5M since 2025 and haven't bought once. Susquehanna cutting its target, even slightly, tells me the sell side is getting less comfortable. I'm using all of that as contrarian ballast, not as proof.

The execution is where I'm deliberately not reckless. I won't sell the gap. I'll sell half the trim into a bounce toward 975, below the 983 EMA and the 996 to 1,005 rejection zone, and finish on a daily close below 898.53. If the bounce never comes, I take the second trigger and accept a worse fill. That's a real cost. And I should say plainly that I don't know why the stock fell today, the bar may still be forming, and I don't know the caller's current holdings, so everything here is sizing guidance to apply to whatever they actually own.

So I'm taking the risk of being early on half the position to avoid the risk of being fully exposed on the other half. I'd rather risk missing a squeeze than own a full position through a gap that this stock has shown it will make again. Aggressive Analyst: I'll start with what I'm giving up, because you both earned some of it.

The calendar backstop is right. The trade text already says to be near half before October 28, but the two price triggers don't enforce that, and the last seven closes sat inside a band under 1% wide, so chop isn't hypothetical. I'll take the neutral analyst's version, scaling out across the last three sessions rather than dumping everything on the final day. I'll also take 910.39 over 898.53 for the second slice. He's right that 898.53 is a stop-loss dressed up as a trim, and the SuperTrend flip gets us smaller sooner. And I'll drop the sentiment ballast. Eleven labeled posts, Cramer and split chatter were never the case, and the argument stands without them.

Where I won't move is the sizing. The gap between 0.4x and 0.5x is the difference between losing 3.5% and 4.35% of an allocation on a repeat of 7/22. That's under a point, and the trade says "about 0.5x," so I'm fine anywhere in that band. But 0.25x isn't a refinement, it's a different bet. The conservative analyst's math is symmetric: what he saves on a gap he gives up on a pop. He says selling ahead of an event isn't a verdict on the thesis, and I agree, which is why I stop at half. Valuation tells me the bar is high, which is why I trim. It doesn't tell me the bar will be missed, which is why I don't go further. The plan already has a lower tier too: a weekly close under about 838 cuts the residual to 0.25x or exits.

On valuation, the neutral analyst is right that 96x is market cap over operating income and that cash isn't tagged. But implied debt is only around $3.4B. Even if we assumed a made-up $15B of net cash, 96x becomes about 90x, which doesn't rescue anything. The 26% incremental figure is gross margin, and the multiple is paid on operating income, where incremental margin was 13.8% in Q2 and 10.4% in Q1. Splitting the difference between $9.88 and $25.27 gives roughly $17.60 of EPS, which is still above 50x for a 5.9% operating margin business.

The evidence for holding, like OBV, the 50 above the 200 and revenue up 22%, is real but backward-looking and already in the price. The 17.7% run from 874.76 to 1,029.21 had no earnings print and Fed meeting waiting at the end of it, and one session erased it. I'd also push back on the neutral analyst's re-entry rule. If we sell near 972 and add back on a reclaim of 1,004, we're paying up on part of the book. I'd rather decide re-entry after the print and the Fed, based on how the stock actually reacts.

The conservative analyst also reads "no statistical edge" too broadly. A daily Z-score of -1.04 says there's no mean-reversion advantage. It doesn't say a 3.5% touch of 975 is unlikely. With ATR at 4.3% and nine sessions, that's not a long shot, though that's my rough arithmetic and not a figure from the data pack. I won't bet the plan on it, which is why I'm taking the backstop.

Finally, selling half is also an offensive move. If this gaps to 860 into a hawkish Fed, the half we sold is capital we can use on a dislocation near or below the 200 SMA, with the print already known. If the print is great, we still own half of the move. At 0.25x we'd have too little to ride, and with a reclaim-based re-entry we'd be chasing.

The usual caveats apply. The 10/14 bar may still be forming, so none of these levels should become orders until it's final. We don't know why the stock fell, and we don't know the caller's holdings. Everything here is a fraction of whatever they own. If they're flat, the Sell means don't buy, not short. Aggressive Analyst: I'll start where we've landed, because it's closer than the tone suggests. All three of us can live with 0.4x as the most you carry into October 28. We all want a target residual, not a fixed fraction sold, no new money, and a re-entry decision after the Fed. I'm taking the neutral analyst's glide path: a third done by the October 20 close, two thirds by the 23rd, everything by the 27th. The conservative analyst is right that price triggers alone leave the first six sessions thin, and I'd rather be a scheduled seller than a hopeful one.

I have two amendments. If the bounce does come to 970 or so, finish early instead of waiting on the calendar. That's the best price the plan will see, and the calendar can't buy it. And confirm the release timing, since the schedule assumes the report lands before the open on the 28th. If it's after the close, the 28th is one more session to spread across.

Now what I'm giving up. I said one session erased the run from 874.76 to 1,029, and the neutral analyst is right that it didn't. The close has retraced about 57% of it, and today's session alone was about 40%, though it did put us below the 9/30 close. "Priced for perfection" is also too strong for 942 as opposed to 1,170, so I'll say priced for a lot. And I'm moving my ceiling from 0.5x to 0.4x. The conservative analyst's drift-to-910-then-gap path is realistic, and 0.4x is where the trade, the group and that stress test meet.

I'm still not moving on 0.25x as the default. From 0.25x to 0.4x is 0.15 of an allocation. On a repeat of the 8.7% gap, that's about 1.3 points of one allocation. On the conservative analyst's path, down to 910 and then a gap to about 831, it's about 1.8 points, and I'll own the bigger number. On a matching pop it's the same size in the other direction. If a standard allocation is around 5% of the book, which I'm assuming and can't see, the whole dispute is under ten basis points of the portfolio. His point that a realized loss shrinks the capital base and a missed gain doesn't is real, but it bites in deep drawdowns, not at this scale.

The neutral analyst also gave us a way to settle it with data. Size to the options-implied move, which none of us has and the caller can look up in a minute. A loss budget of 3 to 3.5% of an allocation on a repeat of the worst gap in the pack gives 0.35x to 0.4x. If the implied move into the week of the 29th is near 12%, go toward 0.25x. If it's 6% or less, sit at the 0.4x cap. The 0.05x between the neutral analyst's default and mine is about four tenths of a point of one allocation, and I won't spend another paragraph on it.

On the base rate, the conservative analyst puts the odds of another 6% drop inside nine sessions at one in five to three in ten, and he flagged that it's rough arithmetic. I agree it argues for being smaller. It argues just as hard against dumping size into the hole right after a heavy-volume gap, which is why I like a first checkpoint four sessions out that leaves room to use a bounce. On his own numbers, most of the time nothing like that happens in the window, and then the size we kept is doing the work.

On dry powder, more cash is better ammunition, but only if the dislocation shows up. If the print is clean and the Fed holds, that cash buys back higher, and the stock we kept is the only part that participated. That's the case for the middle. The weekly-close tier near 838 isn't event protection, and I'm not selling it as that. A weekly close below it by October 23 would take an 11% fall in seven sessions with no catalyst, so it's really a post-event tier. It decides what to do with the residual once we know the print, which is when the question would get asked anyway.

The neutral analyst's tax point is fair, and it's one more reason to sell to target and no further. The thing none of us can build is the bridge from a $9.88 run-rate to $25.27 of forward EPS, plus where that free cash flow goes when deposits unwind. That's what I'd want answered on the call, and until then we're sizing for not knowing.

The caveats are the same. The 10/14 bar may still be forming, so no level becomes an order until it's final. We don't know why the stock fell or what the caller holds. If they're flat or already under 0.4x, Sell means don't buy, not short. Aggressive Analyst: We're down to a very small disagreement, so I'll say where I'm moving and where I'm not.

First, the conservative analyst is right about the stress path. If the stock drifts to 910 on the 16th and then gaps 8.7%, a plan that has sold only a third of the trim leaves us at 0.55x to 0.8x going into the damage. That's 5 to 7% of an allocation against a 3% budget. A close under 910.39 should take us straight to target over the next two sessions. By then the 200 SMA and the daily stop are both gone, so the reason to wait for a bounce is gone too. I also called 898.53 a stop dressed up as a trim, but this is different. It's a backstop that enforces the target when the earlier checkpoints haven't finished the job.

Second, my chop argument was weak. The neutral analyst is right that if most windows are quiet, the extra size does no work in them either. The extra size is a bet on the print, and I should defend it that way. I'm also dropping the "ten basis points" line. It assumed an allocation I can't see. The formula is scale-free anyway, because the caller backs into the number from their own loss budget.

Third, the placeholder. We all accept the rule of about 3% divided by the options-implied move, with a 0.25x floor and a 0.4x cap. I'll take the neutral analyst's 0.3x while that number is missing. I won't take 0.25x, because stacking an ATR day on the worst gap in the pack double counts. The 8.7% gap was already the worst of four big drops. If the report lands after the close on the 28th and collides with the Fed, the implied move will show it, and the formula will push us toward the floor. The 0.05x gap is about 0.4 points of one allocation on a repeat of the gap or on a matching pop. On the first checkpoint it's under 2% of the position. That's too small to keep arguing over.

Where I still hold ground is the upside. The conservative analyst says no Fed outcome is a catalyst. I agree a hold isn't one, but it removes a tail. The stock also ran 17.7% in three weeks, from 874.76 to 1,029.21, with no catalyst. It doesn't need good news to move up 5 to 8%, and a quarter position can't capture that. I'm not claiming the print will be good. Orders, margin, guidance and the Fed all cut both ways, and nobody here can bridge $9.88 of run-rate EPS to $25.27. That uncertainty argues for a middle size, so I'm settling on the middle. The sector-beta point also fits the plan. If an ORCL or neocloud headline can gap the stock without any GEV news, that's a reason to start selling now with resting limits, not a reason to cut deeper. On taxes, a taxable account with large embedded gains is a good reason for the caller to sit at the top of the band, but not a reason to set the default there.

So here's where I land. The Sell stays, as a trim to a target residual and not a fixed fraction sold. The target is about 3% divided by the implied move into the weekly expiry that spans the 28th and 29th, floored at 0.25x and capped at 0.4x, with 0.3x if the caller can't get the number. Place resting sells around 970 to 975 starting Thursday, once tonight's bar is final, and finish the whole job if they fill. Otherwise a third is done by the close on the 20th, two thirds by the 23rd and everything by the 27th, adjusted once the release timing is confirmed. A close under 910.39 takes us to target over the next two sessions. No new money, no averaging down, and no add-back before the Fed, even on a reclaim of 1,004. Decide on re-entry after the 29th, in pieces, based on how the stock actually reacts.

The write-up should also fix two labels. The 975 "entry" is a sell limit. The 837.76 "stop loss" is a post-event regime line for whatever is left, not protection against the gap.

The caveats are the same. The 10/14 bar may still be forming. We don't know why the stock fell, and we don't know the release timing or the caller's holdings. If they're already at or under target, there's nothing to sell, and the Sell means don't buy, not short. Aggressive Analyst: I'll take the last open change first. Sizing off the larger of the options-implied move and 8.7% is fair. The implied number is the market's central guess, and 8.7% is a gap this stock has actually delivered. The rule only bites if the options come back under about 8.7%, and then it moves the residual from 0.4x to about 0.35x. That's under half a point of one allocation, so 0.35x is the working ceiling and 0.4x is the line we never plan to touch. I'm not spending another round on 0.05x.

The neutral analyst is also right that my sector-beta point cuts against me. If an ORCL or neocloud headline can gap this stock with no GEV news, a bounce to 975 is a bonus. The calendar is the plan. The resting limits cost nothing, so they go in, but the schedule shouldn't lean on them.

I owe two retractions. I used the 17.7% run from 874.76 to show the stock doesn't need a catalyst to rise 5 to 8%. That run started at the close of an 8.6% gap-down, so it was a rebound from a washed-out low and I shouldn't have leaned on it. By the same standard, the conservative analyst's "relief will be smaller than the hit" is a directional lean, and he labeled it judgment himself. Neither of us should size off it. One small correction: today's session gave back about 40% of that run, and the 57% figure is the retrace from the 10/6 peak close across the week. It doesn't change the lesson. This stock moves several points either way without a visible reason, so we should size to volatility, not to a view.

Here's where I'd push, because it's the soft part of the plan. We've nailed the way out and left the way back as "in pieces, based on how the stock reacts." That's how a good trim turns into a regretted one. You sell on schedule, then freeze or chase. Before the 28th, decide what each outcome triggers. If the stock gaps down toward the 200 SMA and the print itself is fine, the cash exists to buy that dislocation with the event risk gone. If it's flat, rebuild slowly. If it gaps up, don't anchor to the 972 you sold at. Ask whether you'd buy a third of the missing size at that price with the print known. Rebuilding toward the standard allocation in thirds over a couple of weeks is my suggestion, not something from the data. Being small going in only pays if you act once the risk is gone. I'll also own the cost: if the print is clean and the stock gaps up 8%, we hold 0.3 to 0.35x of it and rebuy higher. That's the price of the trim, and I'd pay it.

On the options number, two errors point in opposite directions. The conservative analyst is right that the implied move is a central estimate, not a worst case. But an expiry just after the 29th also prices the ordinary sessions leading into it, and on a stock with a 4.3% ATR those aren't quiet. So the quoted move overstates the event-only gap. That second point is my reasoning, not a figure from the pack. Since the errors offset, I wouldn't fine-tune the formula and would let the floor and cap do the work.

Two housekeeping items. The pack gives the Fed date as the contract's resolution date, so confirm the actual decision date. Finishing by the 27th covers us either way. And 910.39 comes from a bar that may still be forming, so refresh it once the bar is final.

I'll sign the converged plan. The Sell stands as a trim to a target residual of about 3% divided by the larger of the implied move and 8.7%, floored at 0.25x and capped at 0.4x, with 0.3x if nobody can find the number. Resting sells go in around 970 to 975 from Thursday, and a fill finishes the job. Otherwise a third is done by the close on the 20th, two thirds by the 23rd and everything by the 27th. A close under 910.39 takes us to target over two sessions. There's no new money and no add-back before the Fed, even on a reclaim of 1,004. The 975 "entry" is a sell limit, 837.76 is a post-event regime line and not gap protection, and 898.53 is retired.

The caller needs three numbers: the implied move, the release time, and their current weight against a standard allocation. If they're already at or under target, the Sell means don't buy, not short.